Healthleap Raises $38M in Seed and Series A Funding to Expand Hospital Screening AI

South Africa-founded clinical artificial intelligence venture Healthleap has secured $38 million in combined seed and Series A funding, according to Disrupt Africa. The financing includes an $8 million seed round backed by Sequoia Capital and First Round Capital, alongside a $30 million Series A round led by Hummingbird Ventures. Healthleap intends to use the capital to recruit additional staff across its engineering, sales, product, and customer support divisions.

Established in 2022 by siblings Josiah and Jemima Meyer, the startup developed software designed to scan electronic health records and flag overlooked medical conditions. The platform reads inpatient files every morning, including laboratory results, clinical notes, medications, and vital signs, according to company statements reported by Disrupt Africa. It calculates risk assessments and pushes the findings directly into existing hospital documentation systems so medical teams can review prioritised individuals earlier during their hospital stays.

Healthleap concentrated initially on identifying disease-related malnutrition among hospitalised patients. According to the company, traditional intake questionnaires often miss patients who cannot communicate, leaving many clinically vulnerable cases undiagnosed. Healthleap plans to extend the algorithmic screening tool to additional ailments, including congestive heart failure, pressure ulcers, and common hospital-acquired infections. The company says it now screens adult inpatients daily at more than 50 hospitals.

What it means

For healthcare systems across the Global South, Healthleap's traction demonstrates how automated record analysis can identify acute clinical risks before patient conditions deteriorate. However, deploying such software locally will require emerging economies to digitise fragmented hospital records and overcome shortages in underlying clinical data infrastructure.